Limin: 10,000 t/a Glufosinate-P project is expected to be put into trial operation at the end of the year
Recently, Limin replied on the investor interactive platform : in the face of the severe market situation, what measures the company has in the second half of the year?”
Limin expressed that the current market order volume has increased, the company's sales team will seize this round of opportunities to lay the foundation for the completion of the annual performance. The company's Glufosinate-P project and Tembotrione project are progressing smoothly and will reach production as expected.
In the second half of the year, the company will continue to further promote the integration of the group, and will play a positive impact on the optimization and sharing of resources, the play of management advantages, business collaboration and innovation, and the enhancement of market influence.
It is reported that in response to the national green prevention and control policy and to further consolidate and strengthen the company's product advantages, Hebei Weiyuan Biochemical, a subsidiary of Limin, invested 330 million yuan and actively participated in the construction of f Glufosinate-P project. At present, the construction of the first phase of the project with an annual output of 10,000 tons of Glufosinate-P is progressing smoothly, and it is expected to achieve trial operation by the end of 2023.
According to the company's technical personnel, compared with the traditional Glufosinate ammonium, Glufosinate-P has higher activity, better biological affinity, faster plant absorption and utilization, faster effect, more thorough weed control, with obvious advantages of saving farming time, reducing greening, saving time and saving labor, and broad market prospects.
At present, Weiyuan Biochemical’s environmental impact report of 10,000 t/a Glufosinate-P construction project has entered the stage of publicity. The international and domestic registration work of the company is progressing as planned.
The project uses the green process catalyzed by biological enzymes, the reaction conditions are mild, the process is environmentally friendly and safe, low cost, and has market competitiveness. The process is a bio-green manufacturing technology encouraged by the state. The industrialization of this technology will greatly reduce raw material consumption, reduce carbon and reduce emissions, and is of great significance for the society to achieve "reducing quantity and increasing efficiency" of large varieties of pesticides.
2026-10-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Limin Shares to build a synthetic biology laboratory, focusing on the layout of 'biosynthesis' products
-
Basf plans to close two of its Glufosinate ammonium production sites in Germany to deal with the global serious overcapacity!
-
Basf plans to close two of its Glufosinate ammonium production sites in Germany to deal with the global serious overcapacity!
-
India has decided to impose anti-dumping duties on Sodium cyanide and initiate an anti-dumping investigation on Glufosinate ammonium
-
India has decided to impose anti-dumping duties on Sodium cyanide and initiate an anti-dumping investigation on Glufosinate ammonium
-
China: Details of import and export of main chemical fertilizers in May
-
Invest 45 million! Lier (Hunan) plans to build 100,000 tons of green plant protection formulation project (Glufosinate-P)
-
Invest 45 million! Lier (Hunan) plans to build 100,000 tons of green plant protection formulation project (Glufosinate-P)
-
Invest 45 million! Lier (Hunan) plans to build 100,000 tons of green plant protection formulation project (Glufosinate-P)
-
China agrochemical industry weekly(0531)
Recommend Reading
-
Ingredion Agrees to Acquire Tate & Lyle for $3.6 Billion, Reshaping the Global Specialty Ingredients Market
-
Dow Sounds the Alarm in Southeast Asia: Polymer MDI Prices Jump by $200/ton Amid Market Turbulence
-
Wanhua Chemical and Xingfa Group Jointly Develop 5.32 Billion Yuan Phosphate Mine
-
Mitsubishi Chemical Announces Expansion of Advanced Carbon Fiber Production Capacity in Japan and the United States
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
-
Uses of Sodium Acetate Trihydrate
-
SiO2: Properties, Uses, and Applications
-
FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance
-
MTBE Market Conditions Remain Weak
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate